Pilulka Lekarny as
Pilulka Lékárny a.s. operates a network of pharmacy stores under the Pilulka brand in the Czech Republic, Slovakia, Romania, Hungary, and Austria. The company distributes medicinal products; online sale of pharmacy and related goods for health; and healthy lifestyle and services under the Pilulka brand. It also operates Internet portals, such as Pilulka.cz, Pilulka.sk, Pilulka.ro, Pilulka.hu, and… Read more
Market Cap & Net Worth: Pilulka Lekarny as (PINK)
Pilulka Lekarny as (PR:PINK) has a market capitalization of $13.90 Million (Kč341.04 Million) as of March 18, 2026. Listed on the PR stock exchange, this Czech Republic-based company holds position #42295 globally and #24 in its home market, demonstrating a -0.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pilulka Lekarny as's stock price Kč126.00 by its total outstanding shares 2706678 (2.71 Million).
Pilulka Lekarny as Market Cap History: 2020 to 2026
Pilulka Lekarny as's market capitalization history from 2020 to 2026. Data shows change from $64.53 Million to $13.90 Million (-22.61% CAGR).
Pilulka Lekarny as Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pilulka Lekarny as's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Pilulka Lekarny as's market cap is 0.01 times its annual revenue
7.95x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $64.53 Million | $1.78 Billion | -$25.64 Million | 0.04x | N/A |
| 2021 | $185.87 Million | $2.38 Billion | -$25.67 Million | 0.08x | N/A |
| 2022 | $71.70 Million | $2.45 Billion | -$65.76 Million | 0.03x | N/A |
| 2023 | $27.14 Million | $2.13 Billion | -$174.94 Million | 0.01x | N/A |
| 2024 | $11.86 Million | $1.30 Billion | -$125.74 Million | 0.01x | N/A |
Competitor Companies of PINK by Market Capitalization
Companies near Pilulka Lekarny as in the global market cap rankings as of March 18, 2026.
Key companies related to Pilulka Lekarny as by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Pilulka Lekarny as Historical Marketcap From 2020 to 2026
Between 2020 and today, Pilulka Lekarny as's market cap moved from $64.53 Million to $ 13.90 Million, with a yearly change of -22.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Kč13.90 Million | -25.88% |
| 2025 | Kč18.75 Million | +58.14% |
| 2024 | Kč11.86 Million | -56.30% |
| 2023 | Kč27.14 Million | -62.15% |
| 2022 | Kč71.70 Million | -61.42% |
| 2021 | Kč185.87 Million | +188.03% |
| 2020 | Kč64.53 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pilulka Lekarny as was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.90 Million USD |
| MoneyControl | $13.90 Million USD |
| MarketWatch | $13.90 Million USD |
| marketcap.company | $13.90 Million USD |
| Reuters | $13.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.